適配體市場規模、份額、趨勢分析：產品、應用程序、技術、最終用戶、區域展望、競爭策略、到 2030 年的細分市場預測

全球適體市場預計到 2030 年將保持 16.4% 的複合年增長率，達到 5.92 億美元。慢性病增加、臨床試驗創紀錄、適配體相對於抗體優勢的認識、研發投資的增加以及基於適配體的治療和診斷正在推動市場增長。..

此外，增加適體研究的風險投資資金有望成為市場機會。然而，市場接受度低是市場增長的障礙。此外，對受過高度技術培訓的人力資源的需求和人力資源的短缺是市場上的問題。

本報告調查了全球適體市場，並提供了有關市場規模和預測、COVID-19 的市場影響、市場動□□態、按細分市場/地區的市場分析、競爭形勢、主要公司概況等方面的信息。

目錄

第一章介紹

第二章調查方法

第 3 章執行摘要

第 4 章市場概述

• 簡介
• 市場動態
  • 促進因素
  • 抑制器
  • 市場機會
  • 挑戰
• COVID-19 對市場的影響
• 市場趨勢

第 5 章全球適體市場：按產品（2019-2030 年，金額）

• DNA適體
• XNA適體
• RNA適體

第 6 章全球適體市場：按使用（2019-2030 年，金額）

• 治療方法的發展
• 研發
• 診斷
• 其他

第 7 章全球適體市場：按技術（2019-2030 年，數量）

• SELEX
• 其他

第 8 章全球適體市場：按最終用戶（2019-2030 年，金額）

• 製藥和生物技術公司
• 學術/政府研究所
• CRO
• 其他

第 9 章全球適體市場：按最終區域（2019-2030 年，金額）

• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東
• 非洲

第10章競爭態勢

• 簡介
• 按主要公司：市場份額分析
• 衝突場景
  • 產品發布
  • 夥伴關係、合作、合同
  • 收購
  • 擴展
  • 其他發展

第 11 章公司簡介

• Aptagen, LLC
• Aptamer Group
• Aptamer Sciences, Inc.
• Raptamer Discovery Group
• SomaLogic Inc.

第12章 附錄

Global Aptamers Market is projected to be worth USD 592 million by 2030.

According to SPER Market Research, the Aptamers Market estimated to reach USD 592 million by 2030 with a CAGR of 16.4%. Aptamers are short, single-stranded DNA, RNA, or synthetic XNA molecules, which bind to a specific target molecule. They are used to facilitate discoveries in basic research, ensure food safety and environment monitoring.

Increase in the occurrence of chronic diseases, the record breaking number of clinical trials, and awareness about the pros of aptamers than antibodies, growing investment in R&D, and aptamers-based therapeutics and diagnostics; are the fuel for the growth of aptamers market.

Impact of COVID-19 on the Aptamers Market

The outbreak of COVID-19 boosted the production companies which provide aptamers -based therapeutics & diagnostics.

Scope of the report:

• Market size available for years:2019-2030
• Base year considered: 2021
• Forecast period:2022-2030

Segments covered

• By product type, By Application, By Technology, By End Users, By Region

Geographies covered

• North America, Europe, Asia Pacific, South America and Rest of the World

Companies Covered

• Aptamer Group, Aptamer Sciences, Inc. Aptagen, LLC, Raptamer Discovery Group, SomaLogic Inc.

Drivers: increasing awareness of pros of aptamers over antibodies

Aptamers can better target smaller molecules than antibody. Aptamers are used both in diagnostic & therapeutic applications. It can cross easily the BBB i.e. blood brain barrier, cost effective as compared to antibodies.

Restrains: Low market acceptance as compared to antibodies

Even though there is lots of a pro of aptamers than antibody, it has little affinity, less approval by the market, low acceptance by the scientific community. This is probable the reason for shrinkage of the market.

Opportunities: Growth in the venture capital funding for research on aptamers

Increase in the investment, increase venture capital, for both therapeutic and diagnostic applicable aptamers. This leads to the expansion of this market.

Challenges: Shortage of skilled & trained professionals

Need of trained person, highly technical, lack of personnel is the challenges to this market.

Global Aptamers Market, by Product:

Based upon product type, Aptamers market segmented as; DNA Aptamers, XNA Aptamers, RNA Aptamers.

Global Aptamers Market, by Application;

Based upon Application, Aptamers market segmented as; Therapeutics Development, Research & Development, Diagnostic, Others.

Global Aptamers Market, by Technology:

Based upon the Technology, Aptamers market segmented as; SELEX, Others.

Global Aptamers Market, by End Users:

Based upon the End Users, Aptamers market segmented as; Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs, Others

Global Aptamers Market, by End Region:

The biggest share of Aptamers Market is with North America. This is due to the existence of top market players, accessibility of funds for innovative techniques.

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Dynamics
  • 4.2.1. Drivers
  • 4.2.2. Restraints
  • 4.2.3. Opportunities
  • 4.2.4. Challenges
• 4.3. COVID-19 Impact on the Aptamers Market
• 4.4. Market Trends

5. Global Aptamers Market, by Product, 2019-2030 (USD Million)

• 5.1. DNA Aptamers
• 5.2. XNA Aptamers
• 5.3. RNA Aptamers

6. Global Aptamers Market, by Application, 2019-2030 (USD Million)

• 6.1. Therapeutics Development
• 6.2. Research & Development
• 6.3. Diagnostic
• 6.4. Others

7. Global Aptamers Market, by Technology, 2019-2030 (USD Million)

• 7.1. SELEX
• 7.2. Others

8. Global Aptamers Market, by End Users, 2019-2030 (USD Million)

• 8.1. Pharmaceutical & Biotechnology Companies
• 8.2. Academic & Government Research Institutes
• 8.3. CROs
• 8.4. Others
• 8.5. Global Aptamers Market, by End Users, 2019-2030 (USD Million)

9. Global Aptamers Market, by End Region, 2019-2030 (USD Million)

• 9.1. North America
• 9.2. Europe
• 9.3. APAC
• 9.4. Latin America
• 9.5. Middle East
• 9.6. Africa

10. Competitive Landscape

• 10.1. Introduction
• 10.2. Market Share Analysis, By Key Players
• 10.3. Competitive Scenario
  • 10.3.1. Product Launches
  • 10.3.2. Partnerships, Collaborations and Agreements
  • 10.3.3. Acquisitions
  • 10.3.4. Expansions
  • 10.3.5. Other Developments

11. Company Profiles

• 11.1. Aptagen, LLC
• 11.2. Aptamer Group
• 11.3. Aptamer Sciences, Inc.
• 11.4. Raptamer Discovery Group
• 11.5. SomaLogic Inc.

12. Appendix